4th European Biopharma Congress

Biopharmaceuticals Conference Series
Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria.

The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8% is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable future.
The world of Big Pharma is not only growing, it's standing on its head. Worldwide spending for prescription branded drugs and generic medicines will jump 30% from 2013-2018 at compound annual growth rate of over 5% leading to a jaw-dropping $1.3 trillion in annual global drug sales. The market is also radically shifting position, with traditional strongholds, such as Japan and Europe, flipping over, and emerging markets, such as China, becoming the head

"Major proponents of business- or image-based definitions refuse to recognize biopharmaceuticals as a subset of pharmaceuticals, preferring to lump together and use the term to apply to all pharmaceuticals, associated R&D, companies and industry" says Ronald A Rader from nature biotechnology, Nature Publishing Group
I hope this message finds you well. I'm honored to request your participation as a speaker/delegate at “4th European Biopharma Congress” during November 9-11, 2017 at Vienna, Austria. Euro Biopharma 2017 is a three day event with an audience from various areas of Pharma and Biopharma assembling experts from Academy and Research-Professors, Assistant Professors, PhD Scholars, Pharmaceutical Associations and Societies, Pharmaceutical Business Entrepreneurs, Pharmaceutical Manufacturing Companies, Medical Devices Manufacturing Companies, Directors, CEO’s of Organizations, CROs and Clinical Data Management Companies.

Our aim is to bring together bright minds to give talks that are idea-focused, and on a wide range of subjects, to foster learning, inspiration and provoke conversations that matter.

Website: Biopharma Conferences

Benefits of speaker:

• Keynote sessions by world’s most eminent researchers.
• Networking with Experts in the field
• Being a part of global forum of Biopharma professionals
• Upon acceptance the abstract will receive DOI from CrossRef and published in conference proceedings book.
• Top Industry Representation by mostly C-level executives

We also encourage your colleagues and you to come in a group to the conference and avail the best possible discounts on Registration and accommodation.

We believe your voice would be a critical addition to the Euro Biopharma 2017 stage.
Thank you for reading, and we look forward towards receiving your participation confirmation at the earliest convenience.

Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria.

Chris Chappell
Program Manager | Euro Biopharma
Kemp House,
152 City Road,
London EC1V 2NX
Direct:+1-800-216-6499
Email:eurobiopharma@pharmaceuticalconferences.org

This release was published on openPR.